In a study aimed at elucidating the possible mechanism by which hepatitis B core antigen (HBc) promotes doxorubicin resistance in HCC, Wei et al. suggested that HBc led to upregulation of exosomal miR-135a-5p inducing cell proliferation, anti-apoptotic effects, and drug resistance. Here, KRT88P is linked to hepatocellular carcinoma.